Starting ART following cryptococcal meningitis:The optimal time has yet to be defined

T A Bicanic; J N Jarvis; A Loyse; T S Harrison

doi:10.4102/sajhivmed.v14i3.61

Southern African Journal of HIV Medicine (Sep 2013)

Starting ART following cryptococcal meningitis:The optimal time has yet to be defined

T A Bicanic,
J N Jarvis,
A Loyse,
T S Harrison

Affiliations

T A Bicanic: Cryptococcal Meningitis Group, Research Centre of Infection and Immunity, St George’s University of London, London, Cryptococcal Meningitis Group, Research Centre of Infection and Immunity, St George’s University of London, London, United Kingdom
J N Jarvis: Cryptococcal Meningitis Group, Research Centre of Infection and Immunity, St George’s University of London, London, United Kingdom; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
A Loyse: Cryptococcal Meningitis Group, Research Centre of Infection and Immunity, St George’s University of London, London, United Kingdom
T S Harrison: Cryptococcal Meningitis Group, Research Centre of Infection and Immunity, St George’s University of London, London, United Kingdom

DOI: https://doi.org/10.4102/sajhivmed.v14i3.61
Journal volume & issue: Vol. 14, no. 3
pp. 105 – 106

Abstract

Read online

Ever since the public sector rollout of antiretroviral therapy (ART) in 2004, the question of the optimal time to start ART following diagnosis of an opportunistic infection has aroused controversy among South African HIV clinicians and researchers.

Published in Southern African Journal of HIV Medicine

ISSN: 1608-9693 (Print); 2078-6751 (Online)
Publisher: AOSIS
Country of publisher: South Africa
LCC subjects: Medicine: Public aspects of medicine; Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://sajhivmed.org.za/index.php/hivmed

About the journal

Abstract

Keywords